Cargando…
Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum
Multiple myeloma (MM) is a neoplasm of plasma cells that secrete patient specific monoclonal immunoglobulins. A recognized problem in MM treatment is the early recognition of minimal residual disease (MRD), the major cause of relapse. Current MRD detection methods (multiparameter flow cytometry and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747622/ https://www.ncbi.nlm.nih.gov/pubmed/33335255 http://dx.doi.org/10.1038/s42003-020-01515-x |